Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$186M Buy
1,143,636
+175,127
+18% +$27.5M 1.45% 20
2015
Q3
$134M Sell
968,509
-208,204
-18% -$32.8M 1.14% 26
2015
Q2
$181M Sell
1,176,713
-272,599
-19% -$43.7M 1.37% 21
2015
Q1
$232M Sell
1,449,312
-293,006
-17% -$46.1M 1.85% 16
2014
Q4
$278M Buy
1,742,318
+376,445
+28% +$58.7M 2.11% 16
2014
Q3
$192M Buy
1,365,873
+19,074
+1% +$2.49M 1.52% 22
2014
Q2
$159M Buy
1,346,799
+63,534
+5% +$7.35M 1.31% 27
2014
Q1
$158M Buy
+1,283,265
New +$156M 1.26% 30

Other funds holding AMGN

Orbis Holdings's AMGN Position: Q4 2015 in Review

Orbis Holdings increased its Amgen (AMGN) stake by 18% in Q4 2015, buying an estimated $27.5M and bringing the position to 1,143,636 shares worth $186M. The position accounts for 1.45% of the portfolio, ranked #20.

Orbis Holdings first reported a position in AMGN in Q1 2014 and has held it in 8 quarters since. The position peaked at $278M in Q4 2014. 1,455 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

  • Orbis Holdings held 1,143,636 shares of Amgen worth $186M as of Q4 2015.
  • Orbis Holdings bought 175,127 Amgen shares in Q4 2015, an estimated $27.5M.
  • Amgen made up 1.45% of Orbis Holdings's portfolio in Q4 2015, its #20 holding.
  • Orbis Holdings first reported a position in Amgen in Q1 2014 and has held it in 8 quarters since.
  • Orbis Holdings's Amgen position peaked at $278M in Q4 2014.
  • 1,455 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on Orbis Holdings's 13F filing for Q4 2015, filed 16 Feb 2016.